Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection.

Literature DB >> 10816541

Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection.

N Rayhane¹, C Fitting, O Lortholary, F Dromer, J M Cavaillon.

Abstract

Lipopolysaccharide (LPS) pretreatment of mice resulted in a significantly enhanced survival after disseminated Cryptococcus neoformans infection. The survival was associated with reduced fungal burden in tissues. LPS-pretreated mice had lower levels of cytokines in blood, spleen, and lungs and higher levels in brain. Pentoxifylline abolished the beneficial effect of LPS pretreatment.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2000 PMID： 10816541 PMCID： PMC97672 DOI： 10.1128/IAI.68.6.3748-3753.2000

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

24 in total

1. Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: role of T cell-dependent production of interferon-gamma.

Authors: A Nansen; J P Christensen; O Marker; A R Thomsen
Journal: J Infect Dis Date: 1997-07 Impact factor: 5.226

2. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.

Authors: G B Huffnagle; G B Toews; M D Burdick; M B Boyd; K S McAllister; R A McDonald; S L Kunkel; R M Strieter
Journal: J Immunol Date: 1996-11-15 Impact factor: 5.422

3. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury : possible connection to an interleukin-6-dependent pathway.

Authors: U Heemann; A Szabo; P Hamar; V Müller; O Witzke; J Lutz; T Philipp
Journal: Am J Pathol Date: 2000-01 Impact factor: 4.307

4. Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens.

Authors: E Roilides; C A Lyman; S D Mertins; D J Cole; D Venzon; P A Pizzo; S J Chanock; T J Walsh
Journal: Cytokine Date: 1996-01 Impact factor: 3.861

5. Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans.

Authors: K Kawakami; X Qifeng; M Tohyama; M H Qureshi; A Saito
Journal: Clin Exp Immunol Date: 1996-12 Impact factor: 4.330

Review 6. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors: T G Mitchell; J R Perfect
Journal: Clin Microbiol Rev Date: 1995-10 Impact factor: 26.132

7. Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12.

Authors: N Rayhane; O Lortholary; C Fitting; J Callebert; M Huerre; F Dromer; J M Cavaillon
Journal: J Infect Dis Date: 1999-11 Impact factor: 5.226

8. Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats.

Authors: G P Eising; L Mao; G W Schmid-Schonbein; R L Engler; J Ross
Journal: Cardiovasc Res Date: 1996-01 Impact factor: 10.787

9. LPS pretreatment protects from hepatic ischemia/reperfusion.

Authors: L M Colletti; D G Remick; D A Campbell
Journal: J Surg Res Date: 1994-09 Impact factor: 2.192

10. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection.

Authors: O Lortholary; L Improvisi; N Rayhane; F Gray; C Fitting; J M Cavaillon; F Dromer
Journal: Infect Immun Date: 1999-12 Impact factor: 3.441

20 in total

1. IL-12 suppression, enhanced endocytosis and up-regulation of MHC-II and CD80 in dendritic cells during experimental endotoxin tolerance.

Authors: Jing Zhang; Jie-ming Qu; Li-xian He
Journal: Acta Pharmacol Sin Date: 2009-04-06 Impact factor: 6.150

2. IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells.

Authors: Tyler S Cole; Min Zhang; Theodore J Standiford; Michael Newstead; Jay Luther; Jiajie Zhang; Chun-Chia Chen; John Y Kao
Journal: Immunol Lett Date: 2012-03-28 Impact factor: 3.685

3. Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain.

Authors: Ye Yang; José Luis Millán; Joan Mecsas; Karen Guillemin
Journal: Infect Immun Date: 2014-10-27 Impact factor: 3.441

4. Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the toll-like receptor 4/MD-2 complex.

Authors: Shoichiro Ohta; Uleng Bahrun; Rintaro Shimazu; Hidetomo Matsushita; Kenji Fukudome; Masao Kimoto
Journal: Clin Vaccine Immunol Date: 2006-10

10. Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo.

Authors: Charay Jennings; Brenda Kusler; Patricia P Jones
Journal: Innate Immun Date: 2009-04 Impact factor: 2.680